Sana Biotechnology, Inc. (SANA)
USD 1.43
(4.01%)
USD 1.43
(4.01%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 277.79 Million USD | -14.1% |
| 2022 | 323.4 Million USD | -19.33% |
| 2021 | 400.9 Million USD | -65.18% |
| 2020 | 1.15 Billion USD | 106.27% |
| 2019 | 558.24 Million USD | 1074.72% |
| 2018 | 47.52 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 279.01 Million USD | -8.89% |
| 2024 Q1 | 306.23 Million USD | 10.24% |
| 2023 FY | 277.79 Million USD | -14.1% |
| 2023 Q3 | 265.58 Million USD | -24.57% |
| 2023 Q1 | 318.66 Million USD | -1.47% |
| 2023 Q2 | 352.11 Million USD | 10.5% |
| 2023 Q4 | 277.79 Million USD | 4.6% |
| 2022 Q2 | 331.58 Million USD | -4.15% |
| 2022 FY | 323.4 Million USD | -19.33% |
| 2022 Q4 | 323.4 Million USD | -2.61% |
| 2022 Q3 | 332.08 Million USD | 0.15% |
| 2022 Q1 | 345.95 Million USD | -13.71% |
| 2021 Q1 | 422.48 Million USD | -63.31% |
| 2021 Q2 | 353.94 Million USD | -16.22% |
| 2021 Q3 | 402.66 Million USD | 13.77% |
| 2021 Q4 | 400.9 Million USD | -0.44% |
| 2021 FY | 400.9 Million USD | -65.18% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q3 | 1.07 Billion USD | 0.0% |
| 2020 FY | 1.15 Billion USD | 106.27% |
| 2020 Q4 | 1.15 Billion USD | 6.73% |
| 2019 FY | 558.24 Million USD | 1074.72% |
| 2019 Q4 | 558.24 Million USD | 0.0% |
| 2018 FY | 47.52 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | 17.268% |
| Alkermes plc | 933.53 Million USD | 70.243% |
| Agenus Inc. | 462.29 Million USD | 39.91% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 93.142% |
| Aptorum Group Limited | 5.25 Million USD | -5184.513% |
| Ardelyx, Inc. | 130.76 Million USD | -112.44% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 41.932% |
| Bicycle Therapeutics plc | 224.41 Million USD | -23.787% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -113.342% |
| ChromaDex Corporation | 26.5 Million USD | -947.959% |
| Chimerix, Inc. | 19.74 Million USD | -1306.903% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -689.698% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -282.809% |
| CRISPR Therapeutics AG | 346.76 Million USD | 19.891% |
| Precision BioSciences, Inc. | 140.92 Million USD | -97.128% |
| Dyadic International, Inc. | 2.34 Million USD | -11768.194% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1608.129% |
| Fortress Biotech, Inc. | 165.93 Million USD | -67.407% |
| Lantern Pharma Inc. | 2.73 Million USD | -10039.607% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -288.63% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -7772.333% |
| Incyte Corporation | 1.59 Billion USD | 82.554% |
| IO Biotech, Inc. | 17.55 Million USD | -1482.325% |
| Jaguar Health, Inc. | 45.86 Million USD | -505.662% |
| Novavax, Inc. | 2.57 Billion USD | 89.2% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -670.406% |
| Opthea Limited | 264.6 Million USD | -4.986% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -112.531% |
| ContextLogic Inc. | 206 Million USD | -34.851% |
| MiMedx Group, Inc. | 96.33 Million USD | -188.376% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -478.47% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -7771.972% |
| NextCure, Inc. | 14.99 Million USD | -1752.324% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -6772.662% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -4060.446% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -494.349% |
| Vaxcyte, Inc. | 167.44 Million USD | -65.897% |
| PDS Biotechnology Corporation | 33.25 Million USD | -735.238% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -18.102% |
| Pharming Group N.V. | 244.07 Million USD | -13.816% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -2230.087% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -117.381% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4104.348% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4104.348% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -236.992% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -4081.74% |
| Acelyrin, Inc. | 86.35 Million USD | -221.695% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -21281.176% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1831.935% |
| Summit Therapeutics Inc. | 125.25 Million USD | -121.778% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -2830.615% |
| Senti Biosciences, Inc. | 52.57 Million USD | -428.415% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -303.904% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -83.347% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -14102.096% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -20699.677% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -22.466% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -2865.656% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -22.136% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 43.824% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -2445.29% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -909.752% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2194.919% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 42.912% |
| Immix Biopharma, Inc. | 3.72 Million USD | -7363.976% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -634.669% |
| MEI Pharma, Inc. | 8.35 Million USD | -3224.871% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -857.412% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 20.078% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -90.44% |
| Fortress Biotech, Inc. | 165.93 Million USD | -67.407% |
| Precigen, Inc. | 41.64 Million USD | -567.066% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -456.365% |
| AlloVir, Inc. | 45.01 Million USD | -517.112% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -113.134% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -101.591% |
| ImmuCell Corporation | 18.81 Million USD | -1376.442% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -884.174% |
| Onconetix, Inc. | 23.18 Million USD | -1098.371% |
| PureTech Health plc | 125.58 Million USD | -121.203% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -3003.832% |
| Elevation Oncology, Inc. | 34.28 Million USD | -710.317% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -11261.677% |
| Seer, Inc. | 39.36 Million USD | -605.685% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -349.256% |
| Innoviva, Inc. | 568.55 Million USD | 51.14% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -920.248% |
| ESSA Pharma Inc. | 3.49 Million USD | -7848.136% |
| GlycoMimetics, Inc. | 6.9 Million USD | -3924.776% |
| GT Biopharma, Inc. | 6.63 Million USD | -4088.045% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -5.069% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -2.022% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -230.604% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -2742.163% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -922.463% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -8511.672% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -276.582% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1657.216% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -2416.313% |
| Soligenix, Inc. | 7.27 Million USD | -3718.511% |
| Century Therapeutics, Inc. | 175.94 Million USD | -57.89% |
| Kura Oncology, Inc. | 51.66 Million USD | -437.712% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -129.047% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -6621.34% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -4100.168% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -9.974% |
| Autolus Therapeutics plc | 263.9 Million USD | -5.262% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -2550.191% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -212.615% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -492.322% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 21.273% |
| GRI Bio, Inc. | 2.69 Million USD | -10200.074% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -34213.012% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -793.484% |
| IGM Biosciences, Inc. | 220.17 Million USD | -26.168% |
| INmune Bio, Inc. | 18.86 Million USD | -1372.765% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -8.31% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -942.696% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -10118.967% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -8368.612% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -375.225% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -188.889% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -4.932% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 66.247% |
| Verastem, Inc. | 71.18 Million USD | -290.241% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -464.895% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -620.081% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -467.712% |
| Histogen Inc. | 5.69 Million USD | -4776.128% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -6234.2% |
| Surrozen, Inc. | 8.14 Million USD | -3310.595% |
| Organovo Holdings, Inc. | 2.74 Million USD | -10008.916% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -88409.135% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -394.031% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -1582.37% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -443.594% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -33495.525% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -119.209% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -2468.925% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -84.104% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -10554.248% |
| Apollomics, Inc. | 14.15 Million USD | -1862.785% |
| Amarin Corporation plc | 279.58 Million USD | 0.642% |
| Mesoblast Limited | 188.79 Million USD | -47.138% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1863.479% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -53.657% |
| Synaptogenix, Inc. | 5.52 Million USD | -4923.864% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -4078.595% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -63.304% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3146.31% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -15707.107% |
| Exelixis, Inc. | 678.44 Million USD | 59.054% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1065.141% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -69.338% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 53.25% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2501.008% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -17009.526% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -613.626% |
| Gritstone bio, Inc. | 125.91 Million USD | -120.612% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1792.839% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -5359.095% |
| Avid Bioservices, Inc. | 275.66 Million USD | -0.771% |
| Insmed Incorporated | 1.66 Billion USD | 83.283% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -3510.503% |
| MediWound Ltd. | 27.18 Million USD | -921.786% |
| OmniAb, Inc. | 87.4 Million USD | -217.841% |
| Alector, Inc. | 487.66 Million USD | 43.037% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 31.147% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1407.696% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -623.928% |
| Zai Lab Limited | 240.17 Million USD | -15.662% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 55.91% |
| Aura Biosciences, Inc. | 29.22 Million USD | -850.467% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -192.177% |
| Immunic, Inc. | 25.36 Million USD | -995.053% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -301.226% |
| Veracyte, Inc. | 93.71 Million USD | -196.411% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -10516.267% |
| FibroGen, Inc. | 585.72 Million USD | 52.573% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1498.073% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -42436.091% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -4811.945% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 96.372% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -3288.546% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -230.619% |
| TG Therapeutics, Inc. | 169.08 Million USD | -64.292% |
| Galecto, Inc. | 5.89 Million USD | -4611.55% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -3253.368% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 89.391% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -863.823% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -2101.038% |
| XBiotech Inc. | 8.39 Million USD | -3208.241% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1792.839% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -422.364% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 23.495% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -933.302% |
| Theravance Biopharma, Inc. | 169 Million USD | -64.371% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 77.148% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 44.489% |
| Vaxxinity, Inc. | 30.94 Million USD | -797.728% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 71.435% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -4506.004% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 62.724% |
| NexImmune, Inc. | 5.08 Million USD | -5363.814% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -74697.385% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -8934.365% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 96.091% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -5289.821% |
| Scopus BioPharma Inc. | 7.45 Million USD | -3626.547% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -956.488% |
| Ainos, Inc. | 7.39 Million USD | -3656.892% |
| Pluri Inc. | 34.11 Million USD | -714.356% |
| Prothena Corporation plc | 135.01 Million USD | -105.747% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -14.27% |
| Celularity Inc. | 102.92 Million USD | -169.888% |
| Rallybio Corporation | 9.43 Million USD | -2843.97% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1036.4% |
| MeiraGTx Holdings plc | 319.99 Million USD | 13.187% |
| Omeros Corporation | 403.25 Million USD | 31.112% |
| Humacyte, Inc. | 114.67 Million USD | -142.24% |
| Immunocore Holdings plc | 228.15 Million USD | -21.755% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -5598.318% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -261.992% |
| Blueprint Medicines Corporation | 918.64 Million USD | 69.76% |
| CalciMedica, Inc. | 4.02 Million USD | -6796.549% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1491.755% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -80.218% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -223.704% |
| Pulmatrix, Inc. | 15.96 Million USD | -1640.231% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1661.193% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1028.964% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -10.759% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -446.987% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 77.054% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -774.03% |
| Nutriband Inc. | 1.07 Million USD | -25647.345% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -2512.555% |
| Vor Biopharma Inc. | 59.1 Million USD | -370.007% |
| Roivant Sciences Ltd. | 773.95 Million USD | 64.107% |
| Evogene Ltd. | 17.99 Million USD | -1444.152% |
| ProKidney Corp. | 29.21 Million USD | -850.825% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -285.936% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -39304.213% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 85.294% |
| CorMedix Inc. | 11.91 Million USD | -2230.962% |
| BioLineRx Ltd. | 50.7 Million USD | -447.894% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -85.866% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -214.1% |
| Atai Life Sciences N.V. | 49.16 Million USD | -465.056% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -791.725% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1446.559% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -122.883% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -4813.212% |
| MediciNova, Inc. | 3.89 Million USD | -7038.358% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1419.738% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -18367.32% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7792.113% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 30.073% |
| Biomea Fusion, Inc. | 30.69 Million USD | -805.158% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 89.794% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1640.34% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -790.334% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -373.371% |
| Absci Corporation | 58.3 Million USD | -376.456% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1358.384% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -766.424% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -276.464% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -217.539% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -722.603% |
| Allakos Inc. | 74.79 Million USD | -271.416% |
| Imunon, Inc. | 8.53 Million USD | -3156.496% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1134.581% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -141.955% |
| BioAtla, Inc. | 48.98 Million USD | -467.087% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2501.008% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -9896.15% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -112.699% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1854.224% |
| XOMA Corporation | 145.58 Million USD | -90.818% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -725.169% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -304.01% |
| aTyr Pharma, Inc. | 31.59 Million USD | -779.175% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -349.336% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -517.798% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -473.929% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -9579.199% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -3305.153% |
| Akari Therapeutics, Plc | 4.58 Million USD | -5960.057% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1466.52% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 83.159% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -68676.305% |
| UroGen Pharma Ltd. | 243.52 Million USD | -14.073% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 13.484% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -9959.285% |
| Orgenesis Inc. | 35.53 Million USD | -681.745% |
| Entera Bio Ltd. | 1.37 Million USD | -20044.525% |
| GH Research PLC | 6.7 Million USD | -4045.545% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -3985.191% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1375.582% |
| Xencor, Inc. | 283.55 Million USD | 2.033% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -9204.194% |
| Replimune Group, Inc. | 113.21 Million USD | -145.37% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -7293.765% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -168.321% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -68676.305% |
| Portage Biotech Inc. | 4.45 Million USD | -6142.539% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -18367.32% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1105.176% |
| OncoCyte Corporation | 49.29 Million USD | -463.498% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -6615.158% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -34733.677% |
| Purple Biotech Ltd. | 10 Million USD | -2676.542% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -4701.123% |
| scPharmaceuticals Inc. | 57.26 Million USD | -385.135% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2142.432% |
| HilleVax, Inc. | 78.9 Million USD | -252.042% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -5400.851% |
| Tharimmune, Inc. | 1.81 Million USD | -15205.012% |
| Genprex, Inc. | 3.25 Million USD | -8436.424% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -924.348% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -5205.443% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -134750.971% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -77377.214% |
| OKYO Pharma Limited | 7.42 Million USD | -3643.414% |
| Savara Inc. | 37.19 Million USD | -646.916% |
| Curis, Inc. | 57.61 Million USD | -382.179% |
| Daré Bioscience, Inc. | 26.32 Million USD | -955.049% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -608.659% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -19137.742% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1234.324% |
| BeiGene, Ltd. | 2.23 Billion USD | 87.564% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1204.817% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -5.867% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1205.786% |
| Erasca, Inc. | 78.61 Million USD | -253.377% |
| bluebird bio, Inc. | 424.62 Million USD | 34.579% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -42294.834% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 85.302% |
| DBV Technologies S.A. | 42.8 Million USD | -549.049% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -42294.834% |
| Moderna, Inc. | 4.57 Billion USD | 93.924% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -3871.308% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -16674.94% |
| Molecular Templates, Inc. | 31.17 Million USD | -791.191% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1527.376% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 52.765% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -123.118% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -912.476% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -661.995% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -399.313% |
| MacroGenics, Inc. | 154.2 Million USD | -80.143% |
| RenovoRx, Inc. | 4.46 Million USD | -6120.175% |
| Adicet Bio, Inc. | 37.12 Million USD | -648.365% |
| Prime Medicine, Inc. | 60.78 Million USD | -357.047% |
| Aditxt, Inc. | 28.53 Million USD | -873.634% |
| Adagene Inc. | 45.16 Million USD | -515.003% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -153630.749% |
| Quantum-Si incorporated | 26.63 Million USD | -943.119% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 60.177% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -9030.605% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -141.641% |
| SciSparc Ltd. | 1.59 Million USD | -17316.489% |
| Vericel Corporation | 127.7 Million USD | -117.527% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4891.883% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -225.444% |
| Generation Bio Co. | 171.63 Million USD | -61.856% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2305.134% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -564.084% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -9.931% |
| Invivyd, Inc. | 51.71 Million USD | -437.182% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -202.024% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -4170.289% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -267.957% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -27107.933% |
| 2seventy bio, Inc. | 310.12 Million USD | 10.426% |
| ADMA Biologics, Inc. | 193.97 Million USD | -43.21% |
| Clene Inc. | 38.95 Million USD | -613.186% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -668.81% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -8.101% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7792.113% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -46.005% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2180.794% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -40.072% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2177.963% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -477.4% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -425.715% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 24.891% |
| Evaxion Biotech A/S | 17.61 Million USD | -1476.803% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -72.618% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -81.344% |
| Trevena, Inc. | 48.26 Million USD | -475.594% |
| Surrozen, Inc. | 8.14 Million USD | -3310.595% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1186.376% |
| Cingulate Inc. | 10.36 Million USD | -2581.176% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -10001.564% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -644.913% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -7645.475% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -2012.494% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 12.424% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1017.924% |
| Clearmind Medicine Inc. | 3.61 Million USD | -7595.08% |
| Kronos Bio, Inc. | 54.2 Million USD | -412.524% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -490.509% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1120.546% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1284.052% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1125.028% |
| ImmunityBio, Inc. | 1.09 Billion USD | 74.523% |
| Korro Bio, Inc. | 51.75 Million USD | -436.777% |
| Kineta, Inc. | 7.22 Million USD | -3746.483% |
| BioVie Inc. | 9.7 Million USD | -2763.217% |
| Codexis, Inc. | 49.94 Million USD | -456.187% |
| Celularity Inc. | 102.92 Million USD | -169.888% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -188.625% |
| Celcuity Inc. | 51.45 Million USD | -439.927% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -80374.458% |
| Cibus, Inc. | 206.11 Million USD | -34.774% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -554.015% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -954.683% |
| IN8bio, Inc. | 8.77 Million USD | -3066.815% |
| Kodiak Sciences Inc. | 213.59 Million USD | -30.058% |
| Annexon, Inc. | 47.11 Million USD | -489.569% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -210.241% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -188.251% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1929.316% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 89.33% |
| Eyenovia, Inc. | 19.78 Million USD | -1304.394% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -56.869% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3516.625% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1052.716% |
| Arcellx, Inc. | 339.75 Million USD | 18.237% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -2234.787% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -13.136% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -2804.873% |
| Moolec Science SA | 13.94 Million USD | -1892.011% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -543.755% |
| Geron Corporation | 146.12 Million USD | -90.104% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -449.737% |
| Royalty Pharma plc | 6.29 Billion USD | 95.589% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -598.394% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -94257.112% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -11191.104% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -46.859% |
| Humacyte, Inc. | 114.67 Million USD | -142.24% |
| Structure Therapeutics Inc. | 29.05 Million USD | -856.225% |
| 89bio, Inc. | 59.96 Million USD | -363.274% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -949.741% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -23126.839% |
| Genelux Corporation | 8.42 Million USD | -3199.204% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -3951.823% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -103.782% |
| Notable Labs, Ltd. | 4.42 Million USD | -6174.972% |
| Liquidia Corporation | 73.13 Million USD | -279.82% |
| Mustang Bio, Inc. | 17.61 Million USD | -1476.667% |
| Immunovant, Inc. | 48.95 Million USD | -467.446% |
| Quantum-Si incorporated | 26.63 Million USD | -943.119% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -623.74% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -8852.401% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -276.102% |
| Acasti Pharma Inc. | 11.55 Million USD | -2303.677% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1128.752% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -10118.967% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -653.296% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -20283.361% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -4456.972% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1018.554% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1098.21% |
| PepGen Inc. | 34.63 Million USD | -702.151% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2187.492% |
| United Therapeutics Corporation | 1.18 Billion USD | 76.502% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -3877.563% |
| Solid Biosciences Inc. | 38.45 Million USD | -622.328% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3146.31% |
| Immuneering Corporation | 12 Million USD | -2213.331% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -88409.135% |
| Silo Pharma, Inc. | 1.56 Million USD | -17602.053% |
| Belite Bio, Inc | 4.21 Million USD | -6496.842% |
| XOMA Corporation | 145.58 Million USD | -90.818% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -11341.227% |
| Bionomics Limited | 10.15 Million USD | -2634.527% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1192.602% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1112.382% |
| uniQure N.V. | 624.01 Million USD | 55.483% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1856.978% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -153630.749% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -63.231% |
| Forte Biosciences, Inc. | 3.66 Million USD | -7477.55% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -106504.422% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -4017.282% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3516.625% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1498.073% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -2528.624% |
| Altimmune, Inc. | 16.54 Million USD | -1579.421% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 55.028% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1112.382% |
| Compugen Ltd. | 55.77 Million USD | -398.06% |
| Peak Bio, Inc. | 20.75 Million USD | -1238.544% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -151.481% |
| Benitec Biopharma Inc. | 4.96 Million USD | -5498.408% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -75.993% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -269.533% |
| Zura Bio Limited | 21.29 Million USD | -1204.683% |
| PolyPid Ltd. | 17.46 Million USD | -1490.297% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -147.149% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -269.533% |
| Instil Bio, Inc. | 99.8 Million USD | -178.347% |
| argenx SE | 444.95 Million USD | 37.568% |
| Immunome, Inc. | 28.65 Million USD | -869.338% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -3232.05% |
| Verona Pharma plc | 58.84 Million USD | -372.108% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1819.388% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1769.527% |
| CervoMed Inc. | 2.59 Million USD | -10601.852% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -5599.487% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -2081.164% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -2536.858% |
| Moolec Science SA | 13.94 Million USD | -1892.011% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -11753.746% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -399.67% |
| AnaptysBio, Inc. | 364.28 Million USD | 23.743% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2223.461% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -2090.106% |
| NeurAxis, Inc. | 1.91 Million USD | -14423.309% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -613.607% |
| Lumos Pharma, Inc. | 13.33 Million USD | -1983.5% |
| Achilles Therapeutics plc | 19.08 Million USD | -1355.404% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1819.388% |
| 180 Life Sciences Corp. | 5.38 Million USD | -5056.529% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1077.688% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1120.546% |
| Nutriband Inc. | 1.07 Million USD | -25647.345% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -807.88% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1814.362% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 30.772% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -755.458% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -2028.829% |
| Palisade Bio, Inc. | 2.73 Million USD | -10042.132% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -5188.273% |
| Beam Therapeutics Inc. | 478.38 Million USD | 41.931% |
| Neurogene Inc. | 36.54 Million USD | -660.056% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 30.194% |
| AEON Biopharma, Inc. | 159.88 Million USD | -73.741% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -482.986% |
| Sesen Bio, Inc. | 30.98 Million USD | -796.569% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -970.04% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -3554.106% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -41.921% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -44.641% |
| Athira Pharma, Inc. | 30.05 Million USD | -824.221% |
| Vaccinex, Inc. | 5.94 Million USD | -4575.076% |
| HCW Biologics Inc. | 15.05 Million USD | -1745.562% |
| XOMA Corporation | 145.58 Million USD | -90.818% |
| Nektar Therapeutics | 267.04 Million USD | -4.024% |
| Arvinas, Inc. | 644.6 Million USD | 56.905% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1466.52% |
| Merus N.V. | 102.15 Million USD | -171.943% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -89.814% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -192.045% |
| Rezolute, Inc. | 11.73 Million USD | -2267.419% |
| Clene Inc. | 38.95 Million USD | -613.186% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -9656.092% |
| BeyondSpring Inc. | 48.26 Million USD | -475.51% |
| Synlogic, Inc. | 32.89 Million USD | -744.484% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1800.999% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -16900.796% |
| Peak Bio, Inc. | 20.75 Million USD | -1238.544% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -337.752% |
| Krystal Biotech, Inc. | 39.71 Million USD | -599.484% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 26.245% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -178.995% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -64096.05% |
| MannKind Corporation | 721.36 Million USD | 61.491% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1143.756% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -13217.018% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -170.78% |
| Gossamer Bio, Inc. | 249.14 Million USD | -11.498% |
| CohBar, Inc. | 1.03 Million USD | -26775.27% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -2498.868% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1358.384% |
| Legend Biotech Corporation | 589.93 Million USD | 52.911% |
| Mural Oncology plc | 37.92 Million USD | -632.422% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -109.44% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -12002.519% |
| Disc Medicine, Inc. | 22.87 Million USD | -1114.396% |
| Champions Oncology, Inc. | 28.03 Million USD | -890.879% |
| REGENXBIO Inc. | 262.22 Million USD | -5.936% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -8169.244% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2116.316% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -1968.201% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1210.035% |
| Vaxart, Inc. | 34.02 Million USD | -716.438% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1262.447% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -873.623% |
| Cellectis S.A. | 249.57 Million USD | -11.306% |
| Longeveron Inc. | 5.33 Million USD | -5105.04% |
| Repare Therapeutics Inc. | 41.81 Million USD | -564.275% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 88.451% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -360.166% |
| Revolution Medicines, Inc. | 262.39 Million USD | -5.867% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -13084.29% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -3120.415% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -2253.978% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1878.16% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -12814.598% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 94.606% |
| Denali Therapeutics Inc. | 122.96 Million USD | -125.916% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4891.883% |
| Veru Inc. | 32.81 Million USD | -746.602% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -3944.155% |
| Cingulate Inc. | 10.36 Million USD | -2581.176% |
| Passage Bio, Inc. | 39.26 Million USD | -607.537% |
| Context Therapeutics Inc. | 4.19 Million USD | -6527.192% |
| Exicure, Inc. | 8.54 Million USD | -3149.421% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -841.416% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -2549.18% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1160.347% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -70.44% |
| Nuvalent, Inc. | 31.82 Million USD | -772.932% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -4266.697% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -340.787% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1443.294% |
| OmniAb, Inc. | 87.4 Million USD | -217.841% |
| Anew Medical, Inc. | 8.24 Million USD | -3270.538% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -625.515% |
| Lipocine Inc. | 2.63 Million USD | -10455.933% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -957.373% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -590.821% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -942.696% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -222.438% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -5043.362% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -235.714% |
| Ocugen, Inc. | 23.98 Million USD | -1058.291% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -498.602% |
| Q32 Bio Inc. | 233.12 Million USD | -19.159% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -2964.119% |
| Alumis Inc. Common Stock | 53.5 Million USD | -419.22% |
| Equillium, Inc. | 27.95 Million USD | -893.644% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -34.465% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -4837.081% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -4429.503% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -76.572% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -300.088% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -2685.115% |
| Dominari Holdings Inc. | 4.63 Million USD | -5893.376% |
| Edesa Biotech, Inc. | 1.84 Million USD | -14984.026% |
| vTv Therapeutics Inc. | 29.56 Million USD | -839.537% |
| Bio-Techne Corporation | 744.34 Million USD | 62.679% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -120.298% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 19.353% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -584.641% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -859.329% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -200.772% |
| Nkarta, Inc. | 105.6 Million USD | -163.062% |
| BioCardia, Inc. | 4.59 Million USD | -5952.135% |
| Iterum Therapeutics plc | 32.66 Million USD | -750.508% |